Please enable JavaScript to continue using this application.

Compare $SLDB vs $VSTM | Chartloom

Compare

$SLDB vs $VSTM

Solid Biosciences Inc · Verastem Inc

SLDB

Solid Biosciences Inc

VSTM

Verastem Inc

Compare $SLDB vs $VSTM

Comparing Solid Biosciences Inc and Verastem Inc

SLDBSolid Biosciences Inc

VSTMVerastem Inc

SLDBSolid Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

26.1%

52W performance

8.9%

FCF yield

-27.8%

VSTMVerastem Inc

Market cap

$736M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.92x

Rev growth (TTM)

3995.7%

YTD performance

15.9%

52W performance

-6.3%

FCF yield

-23.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SLDB

VSTM

Detailed metrics comparison

SLDB

Solid Biosciences Inc

VSTM

Verastem Inc

Market Cap

SLDB$676M

VSTM$736M

Enterprise Value

SLDB$517M

VSTM$682M

Price

SLDB$6.87

VSTM$8.38

P/E Ratio

SLDBN/A

VSTMN/A

P/S Ratio

SLDB49.66x

VSTM8.41x

EV/Sales

SLDB38.88x

VSTM7.79x

EV/EBITDA

SLDB0.00x

VSTM0.00x

P/B Ratio

SLDB1.96x

VSTM14.07x

P/FCF Ratio

SLDBN/A

VSTMN/A

EV/FCF

SLDB-2.75x

VSTM-3.97x

PEG Ratio

SLDBN/A

VSTMN/A

Forward P/E (NTM)

SLDBN/A

VSTMN/A

Forward P/S (NTM)

SLDBN/A

VSTM4.92x

Revenue (TTM)

SLDB$0

VSTM$88M

Revenue Growth (YoY)

SLDBN/A

VSTM3995.7%

Forward Rev Growth

SLDB822.7%

VSTM61.6%

Gross Margin (TTM)

SLDB0.0%

VSTM87.6%

Operating Margin (TTM)

SLDB0.0%

VSTM0.0%

EBITDA Margin (TTM)

SLDB0.0%

VSTM-181.3%

Net Margin (TTM)

SLDB0.0%

VSTM-231.6%

FCF Margin (TTM)

SLDBN/A

VSTM-196.3%

Net Income (TTM)

SLDB$-207M

VSTM$-203M

FCF (TTM)

SLDB$-188M

VSTM$-172M

EPS (TTM)

SLDB-$1.44

VSTM-$2.02

ROE (TTM)

SLDB-7228.0%

VSTM-16540.0%

ROA (TTM)

SLDB-6137.0%

VSTM-9454.0%

ROIC (TTM)

SLDB-7226.0%

VSTM-7104.0%

Cash

SLDB$159M

VSTM$136M

Debt

SLDB$0

VSTM$82M

Net Cash/Debt

SLDB$159M

VSTM$55M

Current Ratio (TTM)

SLDB13.82x

VSTM2.25x

Quick Ratio (TTM)

SLDB13.24x

VSTM2.12x

Debt/Equity (TTM)

SLDB0.00x

VSTM1.63x

Debt/Assets (TTM)

SLDB0.0%

VSTM0.0%

Interest Coverage (TTM)

SLDBN/A

VSTMN/A

Net Debt/EBITDA (TTM)

SLDB0.00x

VSTM0.00x

Beta

SLDB2.60

VSTM0.58

52W Performance

SLDB8.9%

VSTM-6.3%

YTD Performance

SLDB26.1%

VSTM15.9%

% from 52W High

SLDB-40.0%

VSTM-22.6%

% from 52W Low

SLDB81.3%

VSTM144.3%

Asset Turnover (TTM)

SLDB0.07x

VSTM0.41x

FCF Yield (TTM)

SLDB-27.8%

VSTM-23.3%

Earnings Yield (TTM)

SLDB-30.6%

VSTM-27.5%

Dividend Yield (TTM)

SLDBN/A

VSTMN/A

Rule of 40

SLDB0.0

VSTM3,799.4

EV/GP/RG

SLDBN/A

VSTM0.13

Ticker research

View SLDB research View VSTM research

Metric	SLDB Solid Biosciences Inc	VSTM Verastem Inc
Market & Valuation
Market Cap	$676M	$736M
Enterprise Value	$517M	$682M
Price	$6.87	$8.38
P/E Ratio	N/A	N/A
P/S Ratio	49.66x	8.41x
EV/Sales	38.88x	7.79x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.96x	14.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.75x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.92x
Revenue & Growth
Revenue (TTM)	$0	$88M
Revenue Growth (YoY)	N/A	3995.7%
Forward Rev Growth	822.7%	61.6%
Profitability
Gross Margin (TTM)	0.0%	87.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-181.3%
Net Margin (TTM)	0.0%	-231.6%
FCF Margin (TTM)	N/A	-196.3%
Net Income (TTM)	$-207M	$-203M
FCF (TTM)	$-188M	$-172M
EPS (TTM)	-$1.44	-$2.02
ROE (TTM)	-7228.0%	-16540.0%
ROA (TTM)	-6137.0%	-9454.0%
ROIC (TTM)	-7226.0%	-7104.0%
Financial Health
Cash	$159M	$136M
Debt	$0	$82M
Net Cash/Debt	$159M	$55M
Current Ratio (TTM)	13.82x	2.25x
Quick Ratio (TTM)	13.24x	2.12x
Debt/Equity (TTM)	0.00x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	0.58
52W Performance	8.9%	-6.3%
YTD Performance	26.1%	15.9%
% from 52W High	-40.0%	-22.6%
% from 52W Low	81.3%	144.3%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.41x
FCF Yield (TTM)	-27.8%	-23.3%
Earnings Yield (TTM)	-30.6%	-27.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,799.4
EV/GP/RG	N/A	0.13
Ticker research	View SLDB research	View VSTM research

Valuation

P/S Ratio

VSTM

8.41x

SLDB

49.66x

EV/FCF

VSTM

-3.97x

SLDB

-2.75x

Growth & revenue

Revenue Growth TTM

VSTM

3995.7%

Forward Revenue Growth

SLDB

822.7%

VSTM

61.6%

Profitability & performance

Gross Margin

VSTM

87.6%

SLDB

0.0%

ROE

SLDB

-7228.0%

VSTM

-16540.0%

FCF Yield %

VSTM

-23.3%

SLDB

-27.8%

52-Week Performance

SLDB

8.9%

VSTM

-6.3%

Detailed metrics comparison

SLDB

Solid Biosciences Inc

VSTM

Verastem Inc

Market Cap

SLDB$676M

VSTM$736M

Enterprise Value

SLDB$517M

VSTM$682M

Price

SLDB$6.87

VSTM$8.38

P/E Ratio

SLDBN/A

VSTMN/A

P/S Ratio

SLDB49.66x

VSTM8.41x

EV/Sales

SLDB38.88x

VSTM7.79x

EV/EBITDA

SLDB0.00x

VSTM0.00x

P/B Ratio

SLDB1.96x

VSTM14.07x

P/FCF Ratio

SLDBN/A

VSTMN/A

EV/FCF

SLDB-2.75x

VSTM-3.97x

PEG Ratio

SLDBN/A

VSTMN/A

Forward P/E (NTM)

SLDBN/A

VSTMN/A

Forward P/S (NTM)

SLDBN/A

VSTM4.92x

Revenue (TTM)

SLDB$0

VSTM$88M

Revenue Growth (YoY)

SLDBN/A

VSTM3995.7%

Forward Rev Growth

SLDB822.7%

VSTM61.6%

Gross Margin (TTM)

SLDB0.0%

VSTM87.6%

Operating Margin (TTM)

SLDB0.0%

VSTM0.0%

EBITDA Margin (TTM)

SLDB0.0%

VSTM-181.3%

Net Margin (TTM)

SLDB0.0%

VSTM-231.6%

FCF Margin (TTM)

SLDBN/A

VSTM-196.3%

Net Income (TTM)

SLDB$-207M

VSTM$-203M

FCF (TTM)

SLDB$-188M

VSTM$-172M

EPS (TTM)

SLDB-$1.44

VSTM-$2.02

ROE (TTM)

SLDB-7228.0%

VSTM-16540.0%

ROA (TTM)

SLDB-6137.0%

VSTM-9454.0%

ROIC (TTM)

SLDB-7226.0%

VSTM-7104.0%

Cash

SLDB$159M

VSTM$136M

Debt

SLDB$0

VSTM$82M

Net Cash/Debt

SLDB$159M

VSTM$55M

Current Ratio (TTM)

SLDB13.82x

VSTM2.25x

Quick Ratio (TTM)

SLDB13.24x

VSTM2.12x

Debt/Equity (TTM)

SLDB0.00x

VSTM1.63x

Debt/Assets (TTM)

SLDB0.0%

VSTM0.0%

Interest Coverage (TTM)

SLDBN/A

VSTMN/A

Net Debt/EBITDA (TTM)

SLDB0.00x

VSTM0.00x

Beta

SLDB2.60

VSTM0.58

52W Performance

SLDB8.9%

VSTM-6.3%

YTD Performance

SLDB26.1%

VSTM15.9%

% from 52W High

SLDB-40.0%

VSTM-22.6%

% from 52W Low

SLDB81.3%

VSTM144.3%

Asset Turnover (TTM)

SLDB0.07x

VSTM0.41x

FCF Yield (TTM)

SLDB-27.8%

VSTM-23.3%

Earnings Yield (TTM)

SLDB-30.6%

VSTM-27.5%

Dividend Yield (TTM)

SLDBN/A

VSTMN/A

Rule of 40

SLDB0.0

VSTM3,799.4

EV/GP/RG

SLDBN/A

VSTM0.13

Ticker research

View SLDB research View VSTM research

Metric	SLDB Solid Biosciences Inc	VSTM Verastem Inc
Market & Valuation
Market Cap	$676M	$736M
Enterprise Value	$517M	$682M
Price	$6.87	$8.38
P/E Ratio	N/A	N/A
P/S Ratio	49.66x	8.41x
EV/Sales	38.88x	7.79x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.96x	14.07x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.75x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	4.92x
Revenue & Growth
Revenue (TTM)	$0	$88M
Revenue Growth (YoY)	N/A	3995.7%
Forward Rev Growth	822.7%	61.6%
Profitability
Gross Margin (TTM)	0.0%	87.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-181.3%
Net Margin (TTM)	0.0%	-231.6%
FCF Margin (TTM)	N/A	-196.3%
Net Income (TTM)	$-207M	$-203M
FCF (TTM)	$-188M	$-172M
EPS (TTM)	-$1.44	-$2.02
ROE (TTM)	-7228.0%	-16540.0%
ROA (TTM)	-6137.0%	-9454.0%
ROIC (TTM)	-7226.0%	-7104.0%
Financial Health
Cash	$159M	$136M
Debt	$0	$82M
Net Cash/Debt	$159M	$55M
Current Ratio (TTM)	13.82x	2.25x
Quick Ratio (TTM)	13.24x	2.12x
Debt/Equity (TTM)	0.00x	1.63x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	0.58
52W Performance	8.9%	-6.3%
YTD Performance	26.1%	15.9%
% from 52W High	-40.0%	-22.6%
% from 52W Low	81.3%	144.3%
Efficiency & Yields
Asset Turnover (TTM)	0.07x	0.41x
FCF Yield (TTM)	-27.8%	-23.3%
Earnings Yield (TTM)	-30.6%	-27.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	3,799.4
EV/GP/RG	N/A	0.13
Ticker research	View SLDB research	View VSTM research